Finance

Beta
Lists
530019:BOM
Jubilant Pharmova Ltd
₹974.00
+0.44%
(+4.25) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 530019...
Open
₹969.80
High
₹981.25
Low
₹964.35
Mkt. cap
154.43B
Avg. vol.
6.91K
Volume
1.59K
Dividend
0.51%
Quarterly dividend
₹1.25
Ex-dividend date
Jul 24, 2026
P/E ratio
38.84
52-wk high
₹1,250.00
52-wk low
₹783.75
EPS
₹25.08
No. of employees
6K
Open
₹969.80
High
₹981.25
Low
₹964.35
Mkt. cap
154.43B
Avg. vol.
6.91K
Volume
1.59K
Dividend
0.51%
Quarterly dividend
₹1.25
Ex-dividend date
Jul 24, 2026
P/E ratio
38.84
52-wk high
₹1,250.00
52-wk low
₹783.75
EPS
₹25.08
No. of employees
6K
News stories
From sources across the web
About Jubilant Pharmova Ltd
CEO-
Employees5.55K
Founded1978
HeadquartersNoida, Uttar Pradesh, India
SectorPharmaceutical industry
Websitejubilantpharmova.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.01B
19.66B
21.22B
22.90B
Cost of goods sold
6.18B
5.96B
7.16B
7.13B
Cost of revenue
6.18B
5.96B
7.16B
7.13B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.91B
6.36B
7.06B
7.67B
Operating expense
10.91B
11.33B
12.37B
13.54B
Total operating expenses
17.09B
17.30B
19.54B
20.68B
Operating income
1.92B
2.37B
1.69B
2.22B
Other non operating income
120.00M
98.00M
205.00M
237.00M
EBT including unusual items
1.54B
1.90B
934.00M
1.76B
EBT excluding unusual items
1.54B
1.96B
1.33B
1.90B
Income tax expense
519.00M
704.00M
376.00M
567.00M
Effective tax rate
33.61%
36.99%
40.26%
32.22%
Other operating expenses
4.02B
3.92B
4.10B
4.70B
Net income
1.03B
1.20B
559.00M
1.19B
Net profit margin
5.41%
6.12%
2.63%
5.21%
Earnings per share
-
7.85
5.01
8.10
Interest and investment income
-
-
-
-
Interest expense
-490.00M
-502.00M
-561.00M
-565.00M
Net interest expenses
-490.00M
-502.00M
-561.00M
-565.00M
Depreciation and amortization charges
981.00M
1.05B
1.21B
1.17B
EBITDA
2.84B
3.38B
2.30B
3.33B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer